Matches in SemOpenAlex for { <https://semopenalex.org/work/W2015173836> ?p ?o ?g. }
- W2015173836 endingPage "737" @default.
- W2015173836 startingPage "726" @default.
- W2015173836 abstract "Dopamine replacement with l-DOPA is the most effective therapy in Parkinson's disease. However, with chronic treatment, half of the patients develop an abnormal motor response including dyskinesias. The specific molecular mechanisms underlying dyskinesias are not fully understood. In this study, we used a well-characterized animal model to first establish the molecular differences between rats that did and did not develop dyskinesias. We then investigated the molecular substrates implicated in the anti-dyskinetic effect of buspirone, a 5HT1A partial agonist. Striatal protein expression profile of dyskinetic animals revealed increased levels of the dopamine receptor (DR)D3, ΔFosB and phospho (p)CREB, as well as an over-activation of the DRD1 signalling pathway, reflected by elevated ratios of phosphorylated DARPP32 and ERK2. Buspirone reduced the abnormal involuntary motor response in dyskinetic rats in a dose-dependent fashion. Buspirone (4 mg/kg) dramatically reduced the presence and severity of dyskinesias (by 83%) and normalized DARPP32 and ERK2 phosphorylation ratios, while the increases in DRD3, ΔFosB and pCREB observed in dyskinetic rats were not modified. Pharmacological experiments combining buspirone with 5HT1A and DRD3 antagonists confirmed that normalization of both pDARPP32 and pERK2 is required, but not sufficient, for blocking dyskinesias. The correlation between pDARPP32 ratio and dyskinesias was significant but not strong, pointing to the involvement of convergent factors and signalling pathways. Our results suggest that in dyskinetic rats DRD3 striatal over-expression could be instrumental in the activation of DRD1-downstream signalling and demonstrate that the anti-dyskinetic effect of buspirone in this model is correlated with DRD1 pathway normalization." @default.
- W2015173836 created "2016-06-24" @default.
- W2015173836 creator A5010843622 @default.
- W2015173836 creator A5034780566 @default.
- W2015173836 creator A5038499724 @default.
- W2015173836 creator A5047109978 @default.
- W2015173836 creator A5053568588 @default.
- W2015173836 creator A5054743025 @default.
- W2015173836 creator A5062853175 @default.
- W2015173836 creator A5066598343 @default.
- W2015173836 creator A5088360720 @default.
- W2015173836 date "2014-04-01" @default.
- W2015173836 modified "2023-10-16" @default.
- W2015173836 title "Buspirone anti-dyskinetic effect is correlated with temporal normalization of dysregulated striatal DRD1 signalling in l-DOPA-treated rats" @default.
- W2015173836 cites W1515339308 @default.
- W2015173836 cites W1524431861 @default.
- W2015173836 cites W1642086117 @default.
- W2015173836 cites W1716703308 @default.
- W2015173836 cites W1756893006 @default.
- W2015173836 cites W1966443363 @default.
- W2015173836 cites W1967348306 @default.
- W2015173836 cites W1969207105 @default.
- W2015173836 cites W1971982338 @default.
- W2015173836 cites W1973254928 @default.
- W2015173836 cites W1979257727 @default.
- W2015173836 cites W1979617003 @default.
- W2015173836 cites W1981821582 @default.
- W2015173836 cites W1986185847 @default.
- W2015173836 cites W1989327482 @default.
- W2015173836 cites W1991935832 @default.
- W2015173836 cites W1992641040 @default.
- W2015173836 cites W2004875858 @default.
- W2015173836 cites W2008429401 @default.
- W2015173836 cites W2016124628 @default.
- W2015173836 cites W2016551235 @default.
- W2015173836 cites W2022209842 @default.
- W2015173836 cites W2025102930 @default.
- W2015173836 cites W2028727583 @default.
- W2015173836 cites W2033092161 @default.
- W2015173836 cites W2034825135 @default.
- W2015173836 cites W2034945701 @default.
- W2015173836 cites W2045588310 @default.
- W2015173836 cites W2051749971 @default.
- W2015173836 cites W2052887259 @default.
- W2015173836 cites W2054281268 @default.
- W2015173836 cites W2057707626 @default.
- W2015173836 cites W2061515934 @default.
- W2015173836 cites W2063476790 @default.
- W2015173836 cites W2063643899 @default.
- W2015173836 cites W2063805684 @default.
- W2015173836 cites W2065434356 @default.
- W2015173836 cites W2069463443 @default.
- W2015173836 cites W2070775710 @default.
- W2015173836 cites W2071132107 @default.
- W2015173836 cites W2071753334 @default.
- W2015173836 cites W2073630554 @default.
- W2015173836 cites W2077103552 @default.
- W2015173836 cites W2078747341 @default.
- W2015173836 cites W2081817881 @default.
- W2015173836 cites W2085743799 @default.
- W2015173836 cites W2085861484 @default.
- W2015173836 cites W2093325927 @default.
- W2015173836 cites W2096643782 @default.
- W2015173836 cites W2097744565 @default.
- W2015173836 cites W2097863680 @default.
- W2015173836 cites W2107758668 @default.
- W2015173836 cites W2112559108 @default.
- W2015173836 cites W2115613566 @default.
- W2015173836 cites W2120048184 @default.
- W2015173836 cites W2139475986 @default.
- W2015173836 cites W2147875467 @default.
- W2015173836 cites W2150030587 @default.
- W2015173836 cites W2152705320 @default.
- W2015173836 cites W2154345556 @default.
- W2015173836 cites W2166977877 @default.
- W2015173836 cites W2168005196 @default.
- W2015173836 cites W2170920257 @default.
- W2015173836 cites W2170947703 @default.
- W2015173836 cites W3185454048 @default.
- W2015173836 doi "https://doi.org/10.1016/j.neuropharm.2013.11.024" @default.
- W2015173836 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24333147" @default.
- W2015173836 hasPublicationYear "2014" @default.
- W2015173836 type Work @default.
- W2015173836 sameAs 2015173836 @default.
- W2015173836 citedByCount "24" @default.
- W2015173836 countsByYear W20151738362014 @default.
- W2015173836 countsByYear W20151738362015 @default.
- W2015173836 countsByYear W20151738362016 @default.
- W2015173836 countsByYear W20151738362017 @default.
- W2015173836 countsByYear W20151738362018 @default.
- W2015173836 countsByYear W20151738362019 @default.
- W2015173836 countsByYear W20151738362020 @default.
- W2015173836 countsByYear W20151738362021 @default.
- W2015173836 countsByYear W20151738362022 @default.
- W2015173836 countsByYear W20151738362023 @default.
- W2015173836 crossrefType "journal-article" @default.
- W2015173836 hasAuthorship W2015173836A5010843622 @default.
- W2015173836 hasAuthorship W2015173836A5034780566 @default.